TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1.

Saved in:
Bibliographic Details
Title: TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1.
Authors: Lu Y; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China.; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Chen Y; Department of Cardiology, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210008, China., Pan X; Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medical, Nanjing, Jiangsu, 210008, China., Ma W; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China., Liu N; Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210001, China., Yang L; Clinical and Translational Research Center, Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, 226001, China., Dong X; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China., Guo H; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China., Li D; State Key Laboratory of Analytical Chemistry for Life Science, Division of Anatomy and Histo-Embryology, Medical School, Nanjing University, No. 22 Hankou Road, Nanjing, Jiangsu Province, 210093, People's Republic of China. lidm@nju.edu.cn.; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, Jiangsu, 210093, China. lidm@nju.edu.cn., Gan W; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China. gwd@nju.edu.cn.; Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medical, Nanjing, Jiangsu, 210008, China. gwd@nju.edu.cn.; No. 321 Zhongshan Road, Nanjing, Jiangsu Province, 210008, People's Republic of China. gwd@nju.edu.cn.
Source: Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2025 Dec; Vol. 48 (6), pp. 2035-2053. Date of Electronic Publication: 2025 Oct 31.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-3436 (Electronic) Linking ISSN: 22113428 NLM ISO Abbreviation: Cell Oncol (Dordr) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41171371
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lu+Y%22">Lu Y</searchLink>; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China.; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Cardiology, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210008, China.<br /><searchLink fieldCode="AU" term="%22Pan+X%22">Pan X</searchLink>; Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medical, Nanjing, Jiangsu, 210008, China.<br /><searchLink fieldCode="AU" term="%22Ma+W%22">Ma W</searchLink>; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China.<br /><searchLink fieldCode="AU" term="%22Liu+N%22">Liu N</searchLink>; Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210001, China.<br /><searchLink fieldCode="AU" term="%22Yang+L%22">Yang L</searchLink>; Clinical and Translational Research Center, Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, 226001, China.<br /><searchLink fieldCode="AU" term="%22Dong+X%22">Dong X</searchLink>; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China.<br /><searchLink fieldCode="AU" term="%22Guo+H%22">Guo H</searchLink>; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China.<br /><searchLink fieldCode="AU" term="%22Li+D%22">Li D</searchLink>; State Key Laboratory of Analytical Chemistry for Life Science, Division of Anatomy and Histo-Embryology, Medical School, Nanjing University, No. 22 Hankou Road, Nanjing, Jiangsu Province, 210093, People's Republic of China. lidm@nju.edu.cn.; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, Jiangsu, 210093, China. lidm@nju.edu.cn.<br /><searchLink fieldCode="AU" term="%22Gan+W%22">Gan W</searchLink>; Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China. gwd@nju.edu.cn.; Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medical, Nanjing, Jiangsu, 210008, China. gwd@nju.edu.cn.; No. 321 Zhongshan Road, Nanjing, Jiangsu Province, 210008, People's Republic of China. gwd@nju.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101552938%22">Cellular oncology (Dordrecht, Netherlands)</searchLink> [Cell Oncol (Dordr)] 2025 Dec; Vol. 48 (6), pp. 2035-2053. <i>Date of Electronic Publication: </i>2025 Oct 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101552938 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-3436 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222113428%22">22113428 </searchLink><i>NLM ISO Abbreviation: </i>Cell Oncol (Dordr) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41171371
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13402-025-01125-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2035
    Titles:
      – TitleFull: TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lu Y
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Pan X
      – PersonEntity:
          Name:
            NameFull: Ma W
      – PersonEntity:
          Name:
            NameFull: Liu N
      – PersonEntity:
          Name:
            NameFull: Yang L
      – PersonEntity:
          Name:
            NameFull: Dong X
      – PersonEntity:
          Name:
            NameFull: Guo H
      – PersonEntity:
          Name:
            NameFull: Li D
      – PersonEntity:
          Name:
            NameFull: Gan W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2211-3436
          Numbering:
            – Type: volume
              Value: 48
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Cellular oncology (Dordrecht, Netherlands)
              Type: main
ResultId 1